SYNCH HAS ASSISTED LIPIDOR AB

News Published 18 januari 2021

Lipidor AB (Nasdaq First North:LIPI) today announced that the company has signed an exclusive licensing agreement with Cannassure Therapeutics Ltd. (TASE:CSURE), an Israeli company specializing in the development and manufacture of innovative medicinal cannabis products. The license agreement was drafted and negotiated by Synch´s Sara Sparring. Under the agreement, Cannassure has the exclusive right to use Lipidor’s […]